Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


European Pharmaceutical Pricing & Reinbursement

29 Oct 2012 - 30 Oct 2012 - London, UK



Bookmark and Share


SMi are proud to present their 18th annual market leading European Pharmaceutical Pricing and Reimbursement conference. This year’s event will bring together experts from a range of industry perspectives to discuss solutions and strategies within key issues such as market access strategies, recent developments in the healthcare landscape and challenges in VBP and AMNOG. As well as exclusive presentations on the latest P&R developments across Europe and further afield, the event will act as a unique forum for attendees to learn, make connections and explore new ideas.

Key benefits of attending:

Hear from experts in the field on Value Based Pricing: Principles and practice

Debate EU policy challenges in access to medicines in Europe with experts from Germany, Italy, UK, Switzerland and Belgium

Analyse market access in Russia, Turkey and Eastern Europe

Learn about the latest regulations within pricing and reimbursement from industry

Understand the facts and consequences of Germany’s AMNOG

Discover the value of collaboration in HTA and managed entry schemes

Consider an international view with perspectives from the Asia-Pac Region and North America

Network with and learn from senior industry representatives from companies such as Sanofi, GSK, Abbott & UCB 

Quote “Technology Network” and save £100

Register online here: http://www.smi-online.co.uk/goto/2012europricing26.asp



Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Identified Compound Stops Cells Making Ribosomes
From study in yeast, researchers have identifed a compound that interferes with the assembly of ribosomes.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!